365 related articles for article (PubMed ID: 16647564)
21. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector.
Lewis BC; Chinnasamy N; Morgan RA; Varmus HE
J Virol; 2001 Oct; 75(19):9339-44. PubMed ID: 11533197
[TBL] [Abstract][Full Text] [Related]
22. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM
Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987
[TBL] [Abstract][Full Text] [Related]
23. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
24. Production and concentration of pseudotyped HIV-1-based gene transfer vectors.
Reiser J
Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549
[TBL] [Abstract][Full Text] [Related]
25. High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction.
Yu H; Eton D; Wang Y; Kumar SR; Tang L; Terramani TT; Benedict C; Hung G; Anderson WF
Gene Ther; 1999 Nov; 6(11):1876-83. PubMed ID: 10602383
[TBL] [Abstract][Full Text] [Related]
26. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes.
Sakoda T; Kasahara N; Hamamori Y; Kedes L
J Mol Cell Cardiol; 1999 Nov; 31(11):2037-47. PubMed ID: 10591030
[TBL] [Abstract][Full Text] [Related]
27. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral vectors: are they the future of animal transgenesis?
Park F
Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
[TBL] [Abstract][Full Text] [Related]
29. Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.
Schauber-Plewa C; Simmons A; Tuerk MJ; Pacheco CD; Veres G
Gene Ther; 2005 Feb; 12(3):238-45. PubMed ID: 15550926
[TBL] [Abstract][Full Text] [Related]
30. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein.
Kameyama Y; Kawabe Y; Ito A; Kamihira M
J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189
[TBL] [Abstract][Full Text] [Related]
31. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
Klages N; Zufferey R; Trono D
Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
33. Transduction of human embryonic stem cells by ecotropic retroviral vectors.
Koch P; Siemen H; Biegler A; Itskovitz-Eldor J; Brüstle O
Nucleic Acids Res; 2006; 34(18):e120. PubMed ID: 16998181
[TBL] [Abstract][Full Text] [Related]
34. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
35. RD114-pseudotyped oncoretroviral vectors. Biological and physical properties.
Kelly PF; Carrington J; Nathwani A; Vanin EF
Ann N Y Acad Sci; 2001 Jun; 938():262-76; discussion 276-7. PubMed ID: 11458516
[TBL] [Abstract][Full Text] [Related]
36. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
Engelstädter M; Buchholz CJ; Bobkova M; Steidl S; Merget-Millitzer H; Willemsen RA; Stitz J; Cichutek K
Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
[TBL] [Abstract][Full Text] [Related]
37. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
38. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo.
Johnson LG; Olsen JC; Naldini L; Boucher RC
Gene Ther; 2000 Apr; 7(7):568-74. PubMed ID: 10819571
[TBL] [Abstract][Full Text] [Related]
39. Retinal cell type expression specificity of HIV-1-derived gene transfer vectors upon subretinal injection in the adult rat: influence of pseudotyping and promoter.
Bemelmans AP; Bonnel S; Houhou L; Dufour N; Nandrot E; Helmlinger D; Sarkis C; Abitbol M; Mallet J
J Gene Med; 2005 Oct; 7(10):1367-74. PubMed ID: 15966018
[TBL] [Abstract][Full Text] [Related]
40. Transduction of human islets with the lentiviral vector.
Kobayashi N; Arata T; Okitsu T; Ikeda H; Kobayashi K; Kosaka Y; Narushima M; Tanaka N; Lakey JR
Transplant Proc; 2004 Sep; 36(7):2203-4. PubMed ID: 15518800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]